IM Cannabis Corp. to Voluntarily Delist from CSE by June 2, 2025

IM Cannabis Corp ( (TSE:IMCC) ) has issued an update.

On May 28, 2025, IM Cannabis Corp. announced its decision to voluntarily delist its common shares from the Canadian Securities Exchange (CSE) while maintaining its NASDAQ listing. The company cited unnecessary costs and regulatory burdens associated with dual listing as reasons for this move. The delisting is expected to create a central marketplace on NASDAQ, enhancing long-term liquidity and shareholder value. The final trading day on the CSE is anticipated to be June 2, 2025, pending approval.

The most recent analyst rating on (TSE:IMCC) stock is a Buy with a C$6.00 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the TSE:IMCC Stock Forecast page.

Spark’s Take on TSE:IMCC Stock

According to Spark, TipRanks’ AI Analyst, TSE:IMCC is a Neutral.

The stock score is primarily influenced by the company’s weak financial performance, despite recent improvements in profitability and growth in the German market. Mixed technical indicators and poor valuation metrics further weigh on the overall score.

To see Spark’s full report on TSE:IMCC stock, click here.

More about IM Cannabis Corp

IM Cannabis Corp. is an international medical cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. It operates through Focus Medical Herbs Ltd. in Israel and Adjupharm GmbH in Germany, distributing cannabis to medical patients and pharmacies.

Average Trading Volume: 320

Technical Sentiment Signal: Sell

Current Market Cap: C$8.02M

Find detailed analytics on IMCC stock on TipRanks’ Stock Analysis page.